Senti Biosciences Holdings
SNTI
17 hedge funds and large institutions have $1.23M invested in Senti Biosciences Holdings in 2026 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
6% more funds holding
Funds holding: 16 → 17 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14.51% less ownership
Funds ownership: 18.11% → 3.6% (-15%)
73% less capital invested
Capital invested by funds: $4.58M → $1.23M (-$3.35M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$105K |
| 2 |
Jane Street
New York
|
+$51.4K |
| 3 |
VF
Virtu Financial
New York
|
+$22.3K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$15K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$721K |
| 2 |
BlackRock
New York
|
-$20.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$19.5K |
| 4 |
HF
HRT Financial
New York
|
-$12K |
| 5 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$9.74K |
SNTI Hedge Fund Activity: Q2 2026 in Review
17 of the 8,153 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q2 2026, worth a combined $1.23M — down 73% from $4.58M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SNTI positions and 4 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $105K. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $721K sold.
- 17 institutional investors held Senti Biosciences Holdings (SNTI) as of Q2 2026, up from 16 in Q1 2026.
- Funds reported $1.23M of Senti Biosciences Holdings stock for Q2 2026, down 73% quarter-over-quarter.
- 6 funds opened new Senti Biosciences Holdings positions in Q2 2026 and 4 closed out, a net change of +2 holders.
- The largest Senti Biosciences Holdings buyer in Q2 2026 was Citadel Advisors, an estimated $105K added.
- The largest Senti Biosciences Holdings seller in Q2 2026 was Nantahala Capital Management, an estimated $721K sold.
Based on aggregated 13F filings for Q2 2026.